📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Improved fluorescence assays to measure the defects associated with F508del-CFTR allow identification of new active compounds. (2017)

First Author: Langron E
Attributed to:  UKDP: Integrated DEmentiA research environment (IDEA) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bph.13715

PubMed Identifier: 28094839

Publication URI: http://europepmc.org/abstract/MED/28094839

Type: Journal Article/Review

Volume: 174

Parent Publication: British journal of pharmacology

Issue: 7

ISSN: 0007-1188